Programmed cell death 1 pathway inhibitors improve the overall survival of small cell lung cancer patients with brain metastases.

Journal of cancer research and clinical oncology(2022)

Cited 3|Views15
No score
Abstract
Immunotherapy plus chemotherapy and radiotherapy for brain metastases showed promising efficacy for small cell lung cancer patients with brain metastases.
More
Translated text
Key words
Brain metastases,Immune checkpoint inhibitors (ICIs),Programmed cell death 1 (PD-1),Programmed cell death ligand 1 (PD-L1),Small cell lung cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined